Innov8 Tools

Products / Population Health & Clinical Programs

VH

Virta Health

Public facts

Type 2 diabetes and metabolic reversal

Clinically supervised nutrition-first program for type 2 diabetes and sustainable weight loss, sold through employers and health plans.

Overview

Virta Health markets virtual, personalized plans that use nutrition to reduce or eliminate diabetes medications, lower blood sugar, and support weight loss, including as a complement or alternative to weight-loss drugs. The homepage cites a peer-reviewed one-year type 2 diabetes study (Hallberg et al., Diabetes Ther. 2018) for medication and weight outcomes, plus internal surveys on ease of eating and coach satisfaction. Virta says it works with leading organizations and health plans nationwide. Members access a coach, care team, resources, and community in the Virta app.

Why it matters Virta is one of the few employer metabolic programs that publishes a peer-reviewed type 2 diabetes care-model study as its primary outcome source.

Target buyer
Employers and health plans covering populations with type 2 diabetes or obesity who want a medically supervised metabolic program.
Pricing model
Not published; sold via organizations and health plans
Homepage stats (31 lbs; 63% fewer diabetes medications excluding metformin; 1.3 point blood-sugar improvement) refer to the 2018 Hallberg study for people with type 2 diabetes completing one year, not a price list.
Availability
National
Research
Last researched 2026-08-23
Public facts category

Key features

  • Nutrition-first, personalized plans
  • Virtual coach and care team via app
  • Community and educational resources
  • Positioned for medication reduction and A1c improvement in type 2 diabetes
  • Described as complement, offramp, or alternative to weight-loss medications

Integrations

  • Employer and health-plan distribution (named as partners generally, not a public roster)
  • Virta member app

Overview

Virta Health provides virtual metabolic care focused on type 2 diabetes and weight. Public copy emphasizes a nutrition-first model that can reduce medications and blood sugar while supporting weight loss, and that can sit beside, replace, or taper weight-loss medications.

The homepage highlights three outcome numbers with footnotes: 31 pounds lost, 63% fewer diabetes medications, and 1.3 improvement in blood sugar. Footnote 1 points to Hallberg SJ et al., Diabetes Ther. 2018, an open-label, non-randomized controlled study; medication reduction is the percent of total diabetes prescriptions eliminated, excluding metformin, for people with type 2 diabetes completing one year. Other homepage stats come from Virta internal surveys (April 2024; December 2023–March 2024).

Virta states it works with leading organizations and health plans across the nation. A 2026 “Notice of Data Event” is linked from the homepage; details were not summarized in this pass.

Key Capabilities

  • Personalized nutrition plans.
  • App access to coach, care team, resources, and community.
  • Clinical goal of medication reduction and glycemic improvement for type 2 diabetes (study-backed claims, not a guarantee).
  • Weight-loss positioning including GLP-1 adjacency (complement/offramp/alternative).

A public list of devices, labs, or prescribing workflows was not on the homepage reviewed.

Integrations & Ecosystem

Distribution is through employers and health plans. Solera Health’s site names Virta as a diabetes-reversal program in its network (Solera member story). That is Solera’s statement, not a Virta partnership confirmation on virtahealth.com.

Pricing

No public PEPM or member fee. Access is typically via a covered organization.

Notes & Limitations

  • Primary clinical citation is a 2018 non-randomized study; it is not an RCT guarantee of 2026 results.
  • Employer-specific landing page (/for-employers) returned 404 in this research.
  • Medication changes require the member’s clinicians; Virta does not replace a treating physician on the public homepage.
  • Data-event notice should be reviewed by security/compliance buyers separately.

Sources

Tags: population health · type 2 diabetes · weight · nutrition · employer benefit